Anika Therapeutics, Inc. (ANIK)
14.90
-0.24
(-1.59%)
USD |
NASDAQ |
May 08, 10:06
Anika Therapeutics Shareholders Equity (Quarterly) : 133.90M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| TELA Bio, Inc. | 6.313M |
| BioCryst Pharmaceuticals, Inc. | -553.84M |
| Masimo Corp. | 788.90M |
| Lantheus Holdings, Inc. | 1.090B |
| Evolus, Inc. | -28.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 179.39M |
| Total Liabilities (Quarterly) | 45.49M |
| Debt to Equity Ratio | 0.1922 |
| Current Ratio | 4.462 |
| Net Debt Paydown Yield | 0.02% |